Broad-spectrum macrolide antibiotics

Release of 「Pyrosin Tablet 500mg」

 

 

KyungDong Pharm Co., Ltd. will launch a new macrolide antibiotic ‘Pyrosin Tablet 500mg’ in September.

Pyrosin tablets are broad-spectrum antibiotics that are highly effective in treating infections caused by gram-positive bacteria, gram-negative bacteria, and atypical bacteria.

The efficacy of Pyrocin Tablets in respiratory tract infections is supported by a range of clinical data. Their strong antibacterial activity against H. pylori, a cause of peptic ulcers, also makes them a first-line option for H. pylori eradication.

The launch of Pyrosin Tablet 500mg will increase the convenience of patients taking high doses of clarithromycin, and is expected to bring about significant growth in the field of internal medicine, where KyungDong Pharm Co., Ltd. has consistently shown strength.

 

 

 

★ Product Information ★

 

1. Product name: Pyrosin tablets 500mg

2. Ingredient content: Clarithromycin 500mg (Clarithromycin 500mg)

3. Efficacy and effect

․ Lower respiratory tract infections: bronchitis, pneumonia, etc.

․ Upper respiratory tract infections: pharyngitis, sinusitis, etc.

․ Skin and skin tissue infections

․ Mycobacterial infections caused by Mycobacterium avium and Mycobacterium intracellulare

․ Eradication of Helicobacter pylori in duodenal ulcer patients

4. Dosage: Adults: 250 mg twice a day, 7 to 14 days (dosage adjustment required in patients with renal failure)

Mycobacterial infection: 500 mg twice a day

Eradication of H.pylori: 500mg 3 times a day for 2 weeks

5. Packaging unit: 30 tablets, 100 tablets

6. Product code: 500mg(648103400)

 

※ For other details, please refer to the product manual.